Methylnaltrexone bromide 12 mg in 0.6 mL Prefilled Syringe
RxNorm 1244060
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1244060 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: methylnaltrexone bromide 12 mg in 0.6 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
0.6 mL methylnaltrexone bromide 20 mg/ML Prefilled Syringe
(Atom ID: 12345229)
PSNPrescribable
Prescribable Name (PSN):
Methylnaltrexone bromide 12 mg in 0.6 mL Prefilled Syringe
(Atom ID: 7254992)
SYPrescribable
Synonym (SY):
Methylnaltrexone bromide 12 mg per 0.6 mL Prefilled Syringe
(Atom ID: 4248535)
Patient Education
Methylnaltrexone Injection
Methylnaltrexone injection is used to treat constipation caused by opioid (narcotic) pain medications in people with chronic (on-going) pain that is not caused by cancer but may be related to a previous cancer or cancer treatment. It is also used to treat constipation caused by opioid pain medications in people with an advanced illness or for active cancer pain. Methylnaltrexone injection is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the effects of opioid (narcotic) medications.
[Learn More]
* Please review the disclaimer below.